Angiotensin II suppresses adenosine monophosphate-activated protein kinase of podocytes via angiotensin II type 1 receptor and mitogen-activated protein kinase signaling

Clinical and Experimental Nephrology

Volumn 17, Issue 1, 2013, Pages 16-23

  Choi, Ji Young ^a   Ha, Tae Sun ^a   Park, Hye Young ^a   Ahn, Hee Yul ^a  

^a Chungbuk National University College of Medicine   (South Korea)

Author keywords

AMP activated protein kinase; Angiotensin II; Angiotensin II type 1 receptor; MAPK; Podocyte

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ANGIOTENSIN II; APELIN RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA; LOSARTAN; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROTECTION; CONCENTRATION (PARAMETERS); CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME REGULATION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; KIDNEY INJURY; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PODOCYTE; PODOCYTE INJURY; WESTERN BLOTTING;

AMP-ACTIVATED PROTEIN KINASES; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOTTING, WESTERN; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME ACTIVATORS; MAP KINASE SIGNALING SYSTEM; MICE; MICROSCOPY, CONFOCAL; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PHOSPHORYLATION; PODOCYTES; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; RECEPTOR, ANGIOTENSIN, TYPE 1; TIME FACTORS;

EID: 84874115451     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0649-8     Document Type: Article

References (29)

1. Aros C, Remuzzi G. The renin-angiotensin system in progression, remission and regression of chronic nephropathies. J Hypertens. 2002;20:S45-53.
2. Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest. 2006;116:288-96.
3. Wolf G. Angiotensin II as a mediator of tubulointerstitial injury. Nephrol Dial Transplant. 2000;15:61-3.
4. Luft FC. Proinflammatory effects of angiotensin II and endothelin: targets for progression of cardiovascular and renal disease. Curr Opin Nephrol Hypertens. 2002;11:59-66.
5. Benigni A, Tomasoni S, Gagliardini E, Zoja C, Grunkemeyer JA, Kalluri R, et al. Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol. 2001;12:941-8.
6. Bonnet F, Cooper ME, Kawachi H, Allen TJ, Boner G, Cao Z. Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension. Diabetologia. 2001;44:874-7.
7. Hardie DG, Carling D. The AMP-activated protein kinase - fuel gauge of the mammalian cell? Eur J Biochem. 1997;246:259-73.
8. Hardie DG. The AMP-activated protein kinase pathway - new players upstream and downstream. J Cell Sci. 2004;117:5479-87.
9. Steinberg GR, Kemp BE. AMPK in health and disease. Physiol Rev. 2009;89:1025-78.
10. Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev. 2007;8:774-85.
11. Fraser S, Mount P, Hill R, Levidiotis V, Katsis F, Stapleton D, et al. Regulation of the energy sensor AMP-activated protein kinase in the kidney by dietary salt intake and osmolality. Am J Physiol Renal Physiol. 2005;288:F578-86.
12. Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, et al. Mammalian AMP-activated protein kinase subfamily. J Biol Chem. 1996;271:611-4.
13. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest. 2008;118:1645-56.
14. Hallows KR, Mount PF, Pastor-Soler NM, Power DA. Role of the energy sensor AMP-activated protein kinase in renal physiology and disease. Am J Physiol Renal Physiol. 2010;298:F1067-77.
15. Mundel P, Reiser J, Zúñiga Mejía Borja A, Pavenstädt H, Davidson GR, Kriz W, et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res. 1997;236:248-58.
16. Ha T-S. High glucose and advanced glycosylation endproducts increased podocytes permeability via PI3K/Akt signaling. J Mol Med. 2010;88:391-400.
17. Nagata D, Takeda R, Sata M, Satonaka H, Suzuki E, Nagano T, et al. AMP-activated protein kinases inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Circulation. 2004;110:444-51.
18. Hattori Y, Akimoto K, Nishikimi T, Matsuoka H, Kasai K. Activation of AMP-activated protein kinase enhances angiotensin II-induced proliferation in cardiac fibroblasts. Hypertension. 2006;47:265-70.
19. Stuck BJ, Lenski M, Bohm M, Laufs U. Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase. J Biol Chem. 2008;283:32562-9.
20. Lee M-J, Feliers D, Mariappan MM. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol. 2007;292:F617-27.
21. Guo Z, Zhao Z. Effect of N-acetylcysteine on plasma adiponectin and renal adiponectin receptors in streptozotocin-induced diabetic rats. Eur J Pharmacol. 2007;558:208-13.
22. Cammisotto PG, Bendayan M. Adiponectin stimulates phosphorylation of AMP-activated protein kinase α in renal glomeruli. J Mol Histol. 2008;39:579-84.
23. Piwkowska A, Rogacka D, Jankowski M, Dominiczak MH, Stepiński JK, Angielski S. Metformin induces suppression of NAD(P)H oxidase activity in podocytes. Biochem Biophys Res Commun. 2010;393:268-73.
24. Eid AA, Ford BM, Block K, Kasinath BS, Gorin Y, Ghosh-Choudhury G et al. AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes. J Biol Chem. 2010;285:37503-12.
25. Lodha S, Dani D, Mehta R, Bhaskaran M, Reddy K, Ding G, et al. Angiotensin II-induced mesangial cell apoptosis: role of oxidative stress. Mol Med. 2002;8:830-40.
26. Bhaskaran M, Reddy K, Radhakrishanan N, Franki N, Ding G, Singhal PC. Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol. 2003;284:F955-65.
27. Wolf G. Role of reactive oxygen species in angiotensin II-mediated renal growth, differentiation, and apoptosis. Antioxid Redox Signal. 2005;7:1337-45.
28. Turnley AM, Stapleton D, Mann RJ, Witters LA, Kemp BE, Bartlett PF. Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J Neurochem. 1999;72:1707-16.
29. Zhang H, Ding J, Fan Q, Liu S. TRPC6 up-regulation in Ang II-induced podocyte apoptosis might result from ERK activation and NF-kappaB translocation. Exp Biol Med (Maywood). 2009;234:1029-36.